Inscripta plans to expand the capabilities of its Onyx
Digital Genome Engineering platform beyond microbes, to include the ability to support mammalian cells including humans, CEO Kevin Ness tells GEN Edge . . .
The post With $125M More in Financing, Inscripta Ramps Up Expansion appeared first on GEN – Genetic Engineering and Biotechnology News.
